Vita Coco Reports Strong Q1 Earnings and Raises 2026 Outlook
Vita Coco's stock surged 18.63% as it reached a 20-day high, reflecting strong investor confidence following its recent earnings report.
The company reported Q1 GAAP EPS of $0.50, surpassing expectations by $0.18, with revenue of $180 million reflecting a 37.4% year-over-year increase, exceeding market forecasts by $31.64 million. Additionally, Vita Coco raised its full-year 2026 net sales guidance to between $720 million and $735 million, driven by mid-to-high teens growth in coconut water and recovery in new business, indicating robust market performance and consumer demand.
This positive earnings report not only highlights Vita Coco's strong financial health but also reinforces its competitive advantage in the coconut water market, positioning the company for continued growth in the coming quarters.
Trade with 70% Backtested Accuracy
Analyst Views on COCO
About COCO
About the author

- Securities Fraud Investigation: Pomerantz LLP is investigating whether Vita Coco and its executives have engaged in securities fraud or other unlawful business practices, which could lead to significant losses for investors.
- Key Contract Risk: A report from NINGI Research alleges that Vita Coco is at risk of losing a key contract with Costco, which represents approximately 25% of its net sales, potentially leading to severe financial repercussions for the company.
- Internal Operational Issues: The report also highlights internal operational challenges for Vita Coco, including supply chain mismanagement, related-party transactions, and poor performance outside its core coconut water business, which may hinder its long-term growth potential.
- Stock Price Volatility: Following the negative news on March 26, 2025, Vita Coco's stock price fell by $3.90, or 11%, closing at $31.55, indicating market concerns regarding the company's future prospects.
- Partnership Announcement: INTENNSE has partnered with Vita Coco, making it the official electrolyte beverage partner for the 2026 season, providing on-site hydration support to enhance the event experience for players and fans alike.
- Electrolyte Superiority: Vita Coco boasts 1149mg of electrolytes per 500ml, significantly surpassing the leading sports drink's 292mg per 500ml, ensuring players maintain peak performance during intense matches and strengthening the brand's competitive edge in the sports beverage market.
- Enhanced Event Experience: The partnership will include on-site activations, product sampling, and a dedicated Vita Coco Night, offering richer interactive experiences for players and fans, thereby increasing INTENNSE's brand value and market appeal.
- Season Schedule: The 2026 season kicks off on June 5 with 10 teams, and fans are encouraged to purchase tickets early to experience the innovative format of INTENNSE live, which is expected to draw greater audience attention and participation.
- Transaction Overview: Vita Coco's Executive Chairman Michael Kirban indirectly sold 50,000 shares of common stock for approximately $3.4 million, indicating a reduction in his holdings amidst strong share price momentum.
- Ownership Changes: This sale reduced Kirban's personal holdings by 2.28%, leaving him with 2,138,529 common shares (both direct and indirect), while he still holds about 1,250,923 unexercised stock options, suggesting ongoing investment interest in the company.
- Historical Trading Comparison: The 50,000-share sale exceeds Kirban's historical average sell size of 33,100 shares, reflecting a significant reduction in available shares over the past 12 months, with current holdings now below 6% of their previous level.
- Trading Plan Context: The transaction was executed under a Rule 10b5-1 trading plan, scheduled in advance without any material non-public information, indicating that this action is not a signal of market confidence but rather a pre-planned move, prompting investors to watch for any new trading plans in the future.
- Sale Overview: Michael Kirban indirectly sold 50,000 shares of common stock through the Michael Kirban Revocable Trust for approximately $3.40 million, representing 2.28% of his total holdings.
- Updated Holdings: Post-transaction, Kirban's direct holdings stand at 143,799 shares, while he retains 1,994,730 shares indirectly through trust entities, indicating a significant remaining stake.
- Options Holdings: Kirban also holds 1,250,923 Non-Qualified Stock Options, which can be converted into common stock, further supporting his continued equity exposure beyond the shares sold.
- Trading Plan Context: The sale was executed under a Rule 10b5-1 trading plan, indicating it was pre-scheduled without material non-public information, mitigating potential misinterpretations of his intent in the market.
- Securities Fraud Investigation: Pomerantz LLP is investigating whether Vita Coco and its executives have engaged in securities fraud or other unlawful business practices, which could lead to significant losses for investors.
- Contract Risk: A report from NINGI Research alleges that Vita Coco may lose a key contract with Costco, representing approximately 25% of its net sales, which would severely impact the company's revenue stream.
- Internal Operational Issues: The report also highlights that Vita Coco is facing internal challenges such as supply chain mismanagement, related-party transactions, and poor performance outside its core coconut water business, potentially hindering the company's long-term growth.
- Stock Price Reaction: Following the release of these negative reports, Vita Coco's stock price fell by $3.90, or 11%, closing at $31.55 per share on March 26, 2025, reflecting market concerns about the company's future prospects.











